XDEMVY

Serial Number 98452213
Registration 7624780
700

Registration Progress

Application Filed
Mar 15, 2024
Under Examination
Approved for Publication
Nov 5, 2024
Published for Opposition
Nov 5, 2024
Registered
Dec 24, 2024

Trademark Image

XDEMVY

Basic Information

Serial Number
98452213
Registration Number
7624780
Filing Date
March 15, 2024
Registration Date
December 24, 2024
Published for Opposition
November 5, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 24, 2024
Registration
Registered
Classes
005

Rights Holder

Tarsus Pharmaceuticals, Inc.

03
Address
15440 Laguna Canyon Rd., Suite 160
Irvine, CA 92618

Ownership History

Tarsus Pharmaceuticals, Inc.

Original Applicant
03
Irvine, CA

Tarsus Pharmaceuticals, Inc.

Owner at Publication
03
Irvine, CA

Tarsus Pharmaceuticals, Inc.

Original Registrant
03
Irvine, CA

Legal Representation

Attorney
Catherine J. Holland

USPTO Deadlines

Next Deadline
1975 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Dec 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 5, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 5, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 16, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 25, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 21, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 10, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Ophthalmic preparations; preparations for destroying parasites; pharmaceutical preparations for treating blepharitis; topical pharmaceutical preparations for treating ocular disorders; eye drops
First Use Anywhere: Aug 18, 2023
First Use in Commerce: Aug 18, 2023

Additional Information

Design Mark
The mark consists of the word "xdemvy" in a stylized font beneath five stylized eyelashes arcing over the word.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005